Discover
XERS
Xeris Biopharma Holdings, Inc.
8.00
2 x 5.85
2 x 10.24
bid
ask
+
0.08
1.01%
2 @ 04:00 PM
7.96 -0.04 (0.50%)
| Ytd | 1.91% | |
| 1y | 71.67% |
7.91
day range
8.20
4.52
52 week range
10.08
| Open | 7.95 | Prev Close | 7.92 | Low | 7.91 | High | 8.20 | Mkt Cap | 1.38B |
| Vol | 2.72M | Avg Vol | 1.74M | EPS | 0.07 | P/E | 114.29 | Forward P/E | 20.05 |
| Beta | 0.90 | Short Ratio | 8.22 | Inst. Own | 62.38% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 6.50 | 200-d Avg | 7.03 | 1yr Est | 11.29 |
XERS News
businesswire.com
Xeris Announces Updates to Its Board of Directors
CHICAGO--(BUSINESS WIRE)--Xeris Announces Updates to Its Board of Directors.
benzinga.com
Xeris Pharmaceuticals Issued Notice Of Allowance From U.S. Patent And Trademark Office Regarding Its
Xeris Pharmaceuticals, Inc., a wholly owned subsidiary of Biopharma Holdings, Inc. (NASDAQ:XERS), a
benzinga.com
Xeris Biopharma Enters Separate Exchange Agreements With Certain Holders Of Its 8.00% Convertible Se
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS), a fast-growing biopharmaceutical company committed to